Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dermatol Ther ; 27(3): 131-4, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24903470
2.
Dermatol Ther ; 27(2): 105-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24703268

RESUMO

An 8-year-old boy with general pustular psoriasis (GPP) and iatrogenic secondary Cushing syndrome was treated successfully with etanercept after he had failed on acitretin, methotrexate, and methylprednisolone therapy. GPP is a severe and very rare variant of psoriasis in children often accompanied by life-threatening complications. Retinoids, cyclosporine, methotrexate, or dapsone used in a small number of case series and case reports were effective. Etanercept is a recombinant human tumor necrosis factor-alpha (TNF-alpha) receptor protein fused with Fc portion of IgG1 that binds to TNF-alpha, approved by Food and Drug Administration for the treatment of moderate-to-severe plaque psoriasis in children and teens who have not responded to other psoriasis treatments. In our patient, etanercept demonstrated significant clinical response associated with long-term efficacy without acute exacerbation, excellent tolerability, and good safety profile.


Assuntos
Imunoglobulina G/uso terapêutico , Imunossupressores/uso terapêutico , Psoríase/tratamento farmacológico , Receptores do Fator de Necrose Tumoral/uso terapêutico , Adolescente , Etanercepte , Humanos , Imunoglobulina G/efeitos adversos , Imunossupressores/efeitos adversos , Masculino , Psoríase/diagnóstico , Indução de Remissão , Fatores de Tempo , Resultado do Tratamento
3.
Dermatol Ther ; 27(3): 140-3, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24112410

RESUMO

We report a case of Alternaria alternata cutaneous and pulmonary infection in a 62-year-old man after heart transplantation treated by azole antifungals. Alternaria spp. belong to a group of opportunistic dematiaceous fungi with worldwide distribution. The cutaneous form of the infection in human is very rare and occurs predominantly among immunosuppressed patients. Therefore, diagnosis is often delayed or not reached at all. Appropriate treatment is not standardized and remains a matter of discussion. According to current studies, the best results are obtained with systemic azole antifungal therapy combined with surgical intervention.


Assuntos
Alternaria/efeitos dos fármacos , Alternariose/tratamento farmacológico , Antifúngicos/administração & dosagem , Dermatomicoses/tratamento farmacológico , Transplante de Coração/efeitos adversos , Pneumopatias Fúngicas/tratamento farmacológico , Infecções Oportunistas/tratamento farmacológico , Triazóis/administração & dosagem , Voriconazol/administração & dosagem , Alternaria/imunologia , Alternaria/patogenicidade , Alternariose/diagnóstico , Alternariose/imunologia , Alternariose/microbiologia , Dermatomicoses/diagnóstico , Dermatomicoses/imunologia , Dermatomicoses/microbiologia , Humanos , Hospedeiro Imunocomprometido , Imunossupressores/efeitos adversos , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/imunologia , Pneumopatias Fúngicas/microbiologia , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/imunologia , Infecções Oportunistas/microbiologia , Resultado do Tratamento
4.
Artigo em Inglês | MEDLINE | ID: mdl-24077232

RESUMO

BACKGROUND: Psoriasis is now known to be associated with multiple other diseases/comorbidities - including the metabolic syndrome, atherosclerosis and gastrointestinal diseases which are all significantly higher in psoriasis patients. Research results however are highly variable and the conclusions are ambiguous. As no similar study has been performed to date in Czech psoriatic patients, this study aimed at identifying risk factors and early stages of selected diseases/comorbidities in the patients. METHODS AND RESULTS: The study was designed as a hospital-based case-control study. 131 patients with chronic plaque psoriasis formed the cases and 267 patients with other skin disorders formed the controls. A comparison was made of basic demographic and anthropometric indicators, metabolic parameters, the presence of specific antibodies (ASCA, AEP, p-ANCA, AGC, EMA, ARA, t-TG, AGA) and non-specific signs of gastrointestinal diseases. The chi squared, MWU tests and binary logistical model were used to evaluate the data. The results showed significant differences (P<0.05) for the following parameters: blood pressure, waist circumference, weight, BMI values, leucocytes values, HDL cholesterol level, glycemia and gliadine antibody IgA level. All differences were to the detriment of psoriasis patients. In the binary logistical model the following parameters were associated with psoriasis: diastolic blood pressure, leucocyte value and glycemia. For all variables included in the logistical model P≤0.001. CONCLUSIONS: The results were coherent and consistent with existing data. They indicate that psoriasis is interconnected with hypertension, higher BMI and a decreased level of HDL cholesterol. These parameters have been clearly demonstrated as risk factors for the development of cardiovascular diseases. Higher levels of gliadine IgA antibodies are one of the diagnostic markers of celiac disease. Higher values of leukocytes may be interpreted as a nonspecific indicator of gastrointestinal inflammatory diseases. The associations between psoriasis and diastolic blood pressure, BMI value and glycemia are statistically significant in the binary logistic regression model. Care for psoriatic patients should focus especially on secondary prevention of predisposing diseases.


Assuntos
Doença Celíaca/epidemiologia , Gastroenterite/epidemiologia , Síndrome Metabólica/epidemiologia , Psoríase/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Autoanticorpos/sangue , Glicemia/análise , Pressão Sanguínea , Índice de Massa Corporal , Peso Corporal , Estudos de Casos e Controles , HDL-Colesterol/sangue , Comorbidade , República Tcheca/epidemiologia , Feminino , Gliadina/imunologia , Hospitais , Humanos , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Circunferência da Cintura , Adulto Jovem
5.
Dermatol Ther ; 25(4): 352-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22950562

RESUMO

The basic principle of the management of lymphedema is so called complex decongestive physical therapy. This therapy is divided into two phases: (i) edema reduction phase--an initial intensive treatment phase aiming for limb volume reduction; and (ii) maintenance phase--following long-term phase to sustain a manageable limb volume. The first phase consists of a number of physical therapeutic approaches which are: manual lymph drainage, pneumatic pump drainage, low-stretch bandaging, exercises, and skin care. Long-term maintenance phase consists of self-lymph drainage, low-stretch bandaging, or compressive garments, and sometimes when indicated pneumatic pump drainage, exercises, and skin care.


Assuntos
Linfedema/terapia , Bandagens Compressivas , Terapia por Exercício , Humanos , Dispositivos de Compressão Pneumática Intermitente , Linfedema/diagnóstico , Linfedema/tratamento farmacológico , Linfedema/etiologia , Massagem , Qualidade de Vida , Creme para a Pele
6.
Dermatol Ther ; 25(1): 95-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22591504

RESUMO

The study describes the case of a patient with a clinical and histopathological diagnosis of pemphigus vulgaris accompanied by severe side-effects of combined immunosuppressive therapy, who achieved a remission of the disease with adalimumab. Pemphigus vulgaris is a chronic blistering disease of the skin and mucous membranes. Before corticosteroids were introduced, mortality was high. Corticosteroids are currently used as first-line therapy. To reduce the dose of corticosteroids, therapeutic combinations with corticosteroid-sparing immunosuppressive agents are used. The therapy brings a number of complications due to its side effects. To achieve a remission of the disease by treating our patient with combined immunosuppressives, we administered adalimumab and achieved a very good clinical response.


Assuntos
Anti-Inflamatórios/uso terapêutico , Anticorpos Monoclonais Humanizados/uso terapêutico , Pênfigo/tratamento farmacológico , Adalimumab , Anti-Inflamatórios/administração & dosagem , Anticorpos Monoclonais Humanizados/administração & dosagem , Quimioterapia Combinada , Feminino , Glucocorticoides/administração & dosagem , Glucocorticoides/efeitos adversos , Glucocorticoides/uso terapêutico , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Pessoa de Meia-Idade , Pênfigo/patologia , Indução de Remissão/métodos , Resultado do Tratamento
7.
Int J Dermatol ; 51(6): 688-92, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22607286

RESUMO

BACKGROUND: Atopic dermatitis (AD) still remains one of the most common childhood inflammatory skin diseases. As a chronic disease, it can have a physical and psychological effect on social functioning of the affected child as well as their family. The objective of this study was to evaluate the quality of life of children with AD of different age groups and their families. METHODS: A total of 203 children with a diagnosis of AD from newborn to 18 years of age and 202 of their parents took part in our study (as one parent did not return the questionnaire). All participants, according to their age, completed the following questionnaires: Infants' Dermatitis Quality of Life Index (IDQOL); Children's Dermatology Life Quality Index (CDLQI) - text and cartoon version; and Dermatitis Family Impact questionnaire (DFI). RESULTS: The mean total IDQOL score in our study was 8.18 (SD = 5.84, n = 120). The mean total CDLQI scores in the groups of children from 7 to 13 and from 14 to 18 years were 8.58 (SD = 4.98, n = 48) and 9.89 (SD = 5.26, n = 35). There was also a proven influence of the child's AD on the quality of life of his parents with the mean score: 7.98 (SD = 6.41, n = 202). CONCLUSIONS: The study demonstrated and confirmed that AD significantly impairs the children's quality of life in all age groups and also quality of life of their families. Such data give us patient-oriented information that is of great importance for understanding the situation of individuals with AD and its influence on members of their family.


Assuntos
Dermatite Atópica/psicologia , Qualidade de Vida , Adolescente , Análise de Variância , Criança , Pré-Escolar , República Tcheca , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pais , Inquéritos e Questionários
8.
Cas Lek Cesk ; 151(11): 523-6, 2012.
Artigo em Tcheco | MEDLINE | ID: mdl-23301587

RESUMO

Lymphogranuloma venereum is a sexually transmitted disease caused by serovars L1-3 of Chlamydia trachomatis. This infection was originally endemic in tropics and transmitted predominantly by heterosexual contact but since the beginning of the century it spreads in industrialized countries mainly among men having sex with men causing them severe proctitis. In the Czech Republic the first case was diagnosed in 2011. Lymphogranuloma venereum can resemble other forms of anorectal disorders inclusive inflammatory bowel diseases and thus it must be included into differential diagnostic considerations. Definitive diagnosis is based on detection of specific serovars of Chlamydia trachomatis by polymerase chain reaction. In patients with lymphogranuloma venereum it is also necessary to exclude other sexually transmitted diseases, particularly syphilis, HIV and also hepatitis C. The therapy of choice is doxycycline administered for three weeks.


Assuntos
Linfogranuloma Venéreo , Diagnóstico Diferencial , Humanos , Linfogranuloma Venéreo/diagnóstico , Linfogranuloma Venéreo/terapia , Linfogranuloma Venéreo/transmissão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...